Ticker Search:  Getting Started | Register | Videos | Newsletter | Partners | Login    

Basics
Structure Therapeutics Inc.
IPO Date: February 3, 2023
Sector: Healthcare
Industry: Biotech
Market Cap: $1.11B
Activated in VL: True
Average Daily Range
Avg Daily Range: $1.11 | 3.21%
Avg Daily Range (30 D): $0.44 | 2.12%
Avg Daily Range (90 D): $0.61 | 2.88%
Institutional Daily Volume
Avg Daily Volume: .67M
Avg Daily Volume (30 D): .71M
Avg Daily Volume (90 D): .81M
Trade Size
Avg Trade Size (Sh.): 86
Avg Trade Size (Sh.) (30 D): 93
Avg Trade Size (Sh.) (90 D): 85
Institutional Trades
Total Inst.Trades: 1,661
Avg Inst. Trade: $1.45M
Avg Inst. Trade (30 D): $1.34M
Avg Inst. Trade (90 D): $1.28M
Avg Inst. Trade Volume: .04M
Avg Inst. Trades (Per Day): 3
Market Closing Trades
Avg Closing Trade: $1.27M
Avg Closing Trade (30 D): $.93M
Avg Closing Trade (90 D): $1.07M
Avg Closing Volume: 36.74K
   
News
Jun 20, 2025 @ 11:30 PM
Structure Therapeutics Announces Two Late-Breaking...
Source: N/A
Apr 14, 2025 @ 3:12 PM
Why Eli Lilly, Novo Nordisk, and Viking Therapeuti...
Source: Rich Smith
Jun 17, 2024 @ 1:53 PM
Could Structure Therapeutics Become the Next Novo ...
Source: newsfeedback@fool.com (Alex Carchidi)
Jun 13, 2024 @ 6:30 AM
Pfizer: Headwinds Dissipating, New Obesity Pipelin...
Source: ONeil Trader
Jun 11, 2024 @ 1:59 PM
Structure Therapeutics (GPCR) Rallying on Obesity ...
Source: Zacks Equity Research
Financials
  TTM Q1 2025 Q4 2024
Basic EPS $-.87 $-.27 $-.22
Diluted EPS $-.87 $-.27 $-.22
Revenue $ M $ M $ M
Gross Profit $ $ $
Net Income / Loss $ -143.32M $ -46.83M $ -36.48M
Operating Income / Loss $ -182.52M $ -56.31M $ -47.06M
Cost of Revenue $ $ $
Net Cash Flow $ 54.29M $ -17.39M $ -2.62M
PE Ratio